MDxHealth SA ADR (MDXH) had the highest return in 2021 by a US stock in the Biotechnology Industry, returning 865,354.5%.
| ASSET | YEAR | % RETURN |
|---|---|---|
MDxHealth SA ADR (MDXH) | 2021 | 865,354.55% |
LakeShore Biopharma (LSB) | 2021 | 923.16% |
BriaCell Therapeutics (BCTXW) | 2021 | 560.56% |
Biofrontera Inc Warrants (BFRIW) | 2021 | 407.04% |
Prothena (PRTA) | 2021 | 305.25% |
Nutriband Inc Warrant (NTRBW) | 2021 | 291.27% |
PDS Biotechnology (PDSB) | 2021 | 268.18% |
Sunshine Biopharma (SBFM) | 2021 | 247.92% |
Bicycle Therapeutics (BCYC) | 2021 | 238.17% |
Anavex Life Sciences (AVXL) | 2021 | 218.17% |
Dynavax Technologies (DVAX) | 2021 | 211.97% |
Kezar Life Sciences (KZR) | 2021 | 208.49% |
BioNTech SE (BNTX) | 2021 | 201.69% |
Star Equity (STRR) | 2021 | 177.25% |
Regencell Bioscience (RGC) | 2021 | 165.42% |
Indivior PLC Ordinary Shares (INDV) | 2021 | 153.68% |
Entera Bio (ENTX) | 2021 | 153.6% |
Lexaria Bioscience (LEXXW) | 2021 | 150% |
Renovaro Biosciences (RENB) | 2021 | 147.12% |
Moderna (MRNA) | 2021 | 136.86% |
Vera Therapeutics (VERA) | 2021 | 134.18% |
Annovis Bio (ANVS) | 2021 | 126.55% |
Cytokinetics (CYTK) | 2021 | 119.24% |
Celldex Therapeutics (CLDX) | 2021 | 115.14% |
Intellia Therapeutics (NTLA) | 2021 | 112.43% |
